A1C: Target goal of less than7% if it can be achieved without significant hypoglycemia (6 to 7% recommended for patients with a life expectancy greater than 10 to15 years and no to mild microvascular complications) Target range of 7.0% to 8.5% is appropriate (if can be safely achieved) for most persons with micro or macrovascular complications, comorbid conditions, or life expectancy of 5 to10 years GLP-1 or SGLT-2在ASCVD或高风险中指示,与A1C和其他医疗无关。血压:BP靶标应通过共同的决策过程来个性化,该过程解决心血管风险,潜在的不良药物效果和患者偏好的目标是在80 mmHg上的BP,而在治疗中,如果可以安全地获得脂质管理:主要预防
主要关键词